Pentixapharm Holding AG (ETR:PTP) | Finanzwire

Basculer en Français

10812	Companies
234244	Keywords
163039	Articles
125257	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

BRIEF

published on 08/06/2026 at 08:05, 2 days 12 hours ago

Pentixapharm Reports Q2 and H1 2026 Results and Advances Phase 3 Program

Financial Results Oncology Pipeline FDA Fast Track Pentixapharm Phase 3 PANDA
PRESS RELEASE

published on 08/06/2026 at 08:00, 2 days 12 hours ago

Pentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program
Pentixapharm Holding AG reports financial results for second quarter and first half of 2026, advancing Phase 3 Panda Program in oncology and cardiovascular sectors

Financial Results Oncology Phase 3 Pentixapharm PANDA Program
BRIEF

published on 07/31/2026 at 09:05, 8 days 11 hours ago

Pentixapharm Holding AG Advances with PentixaFor in Phase 3

Capital Raise Phase 3 PentixaFor Radiopharma PANDA Study
PRESS RELEASE

published on 07/31/2026 at 09:00, 8 days 11 hours ago

Original-Research: Pentixapharm Holding AG (von NuWays AG): BUY
Research update: Pentixapharm Holding AG positioned for Phase 3 with strong financing secured for PentixaFor diagnostic agent. Potential commercial partnering in 2027. Target price EUR 7.20

Financing Phase 3 Pentixapharm Commercial Partnering Diagnostic Agent
BRIEF

published on 07/27/2026 at 20:55, 11 days 23 hours ago

Pentixapharm Raises EUR 20.4 Million Through Capital Increase

Capital Increase FDA Fast Track Pentixapharm [68Ga]Ga-PentixaFor PANDA Phase 3
PRESS RELEASE

published on 07/27/2026 at 20:50, 12 days ago

Pentixapharm Completes Capital Increase – New Shares Placed in Full
Pentixapharm completes capital increase, raising EUR 20.4 million for PANDA Phase 3 activities and U.S. expansion after FDA milestones

Capital Increase U.S. Expansion Pentixapharm PANDA Phase 3 FDA Milestones
BRIEF

published on 07/27/2026 at 20:45, 12 days ago

Pentixapharm Raises EUR 20.4 Million Through Oversubscribed Offering

Capital Increase Clinical Development US Expansion Oversubscription Theranostic Platform
PRESS RELEASE

published on 07/27/2026 at 20:40, 12 days ago

EQS-Adhoc: Pentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today
Pentixapharm Holding AG completes rights offering and private placement, raising EUR 20.4 million for PANDA Phase 3 trial, US market expansion, and CXCR4-based theranostic platform development

Private Placement Capital Increase Pentixapharm Holding AG EUR 20.4 Million PANDA Phase 3 Trial
BRIEF

published on 07/22/2026 at 12:45, 17 days 8 hours ago

Pentixapharm Holding AG Completes Rights Offering

Private Placement Capital Increase U.S. Expansion Rights Offering PANDA Phase 3 Study
PRESS RELEASE

published on 07/22/2026 at 12:40, 17 days 8 hours ago

EQS-Adhoc: Pentixapharm Holding AG: Rights offering successfully completed, remaining shares available for subscription through private placement
Pentixapharm Holding AG successfully completes rights offering and offers remaining shares through private placement for capital increase. Gross proceeds of EUR 16.8 million

Private Placement Capital Increase Rights Offering Pentixapharm Holding AG EUR 16.8 Million

Accesswire

Published on 08/08/2026 at 00:00, 20 hours 50 minutes ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 21 hours 35 minutes ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 21 hours 50 minutes ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 22 hours 20 minutes ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 22 hours 35 minutes ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/08/2026 at 16:25, 4 hours 24 minutes ago

Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 21 hours 29 minutes ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 1 hour ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 day 1 hour ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 1 day 2 hours ago

Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request

Les Echos

Published on 08/07/2026 at 18:54, 1 day 1 hour ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 2 hours ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 17:49, 1 day 3 hours ago

Crédit Agricole CIB announced the publication of the Amendment of its 2025 Universal Registration Document
Published on 08/07/2026 at 08:30, 1 day 12 hours ago

Disclosure of shares outstanding and voting rights - 07.08.2026
Published on 08/06/2026 at 18:26, 2 days 2 hours ago

Air Liquide voting rights as of July 31st 2026

View all LES ECHOS COMFI WIRE